Search Results - Tsai, Max

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
    Paclitaxel-loaded polymeric microparticles: Quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics

    Paclitaxel-loaded polymeric microparticles: Quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics by Tsai, Max, Lu, Ze, Wientjes, M. Guillaume, Au, Jessie L.-S.

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Effects of Lasmiditan on Cardiovascular Parameters and Pharmacokinetics in Healthy Subjects Receiving Oral Doses of Propranolol

    Effects of Lasmiditan on Cardiovascular Parameters and Pharmacokinetics in Healthy Subjects Receiving Oral Doses of Propranolol by Tsai, Max, Case, Michael, Ardayfio, Paul, Hochstetler, Helen, Wilbraham, Darren

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor

    A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor by Tsai, Max, Chrones, Lambros, Xie, Jinhui, Gevorkyan, Hakop, Macek, Thomas A.

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis

    A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis by Naik, Himanshu, Tsai, Max C., Fiedler-Kelly, Jill, Qiu, Ping, Vakilynejad, Majid

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    The pharmacokinetics and pharmacodynamics of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus

    The pharmacokinetics and pharmacodynamics of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus by Dudkowski, Caroline, Tsai, Max, Liu, Jie, Zhao, Zhen, Schmidt, Eric, Xie, Jeannie

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor‐Positive Allosteric Modulator (D1PAM), in Healthy Subjects

    Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor‐Positive Allosteric Modulator (D1PAM), in Healthy Subjects by Wilbraham, Darren, Biglan, Kevin M., Svensson, Kjell A., Tsai, Max, Kielbasa, William

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    TUMOR PENETRATING MICROPARTICLES FOR INTRAPERITONEAL THERAPY OF OVARIAN CANCER

    TUMOR PENETRATING MICROPARTICLES FOR INTRAPERITONEAL THERAPY OF OVARIAN CANCER by Lu, Ze, Tsai, Max, Lu, Dan, Wang, Jie, Wientjes, M. Guillaume, Au, Jessie L.-S.

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Single-dose pharmacokinetics and safety of azilsartan medoxomil in children and adolescents with hypertension as compared to healthy adults

    Single-dose pharmacokinetics and safety of azilsartan medoxomil in children and adolescents with hypertension as compared to healthy adults by Webb, Nicholas J. A., Wells, Thomas, Tsai, Max, Zhao, Zhen, Juhasz, Attila, Dudkowski, Caroline

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    EFFECTS OF CARRIER ON DISPOSITION AND ANTITUMOR ACTIVITY OF INTRAPERITONEAL PACLITAXEL

    EFFECTS OF CARRIER ON DISPOSITION AND ANTITUMOR ACTIVITY OF INTRAPERITONEAL PACLITAXEL by Tsai, Max, Lu, Ze, Wang, Jie, Yeh, Teng-Kuang, Wientjes, M. Guillaume, Au, Jessie L.-S.

    Published 2007
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor–Positive Allosteric Modulator, in Patients With Parkinson Disease

    Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor–Positive Allosteric Modulator, in Patients With Parkinson Disease by Wilbraham, Darren, Biglan, Kevin M., Svensson, Kjell A., Tsai, Max, Pugh, Melissa, Ardayfio, Paul, Kielbasa, William

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Multiscale Tumor Spatiokinetic Model for Intraperitoneal Therapy

    Multiscale Tumor Spatiokinetic Model for Intraperitoneal Therapy by Au, Jessie L.-S., Guo, Peng, Gao, Yue, Lu, Ze, Wientjes, Michael G., Tsai, Max, Wientjes, M. Guillaume

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo‐ and Alprazolam‐Controlled Crossover Study

    Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo‐ and Alprazolam‐Controlled Crossover Study by Wilbraham, Darren, Berg, Paul H., Tsai, Max, Liffick, Emily, Loo, Li Shen, Doty, Erin Gautier, Sellers, Edward

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    A Randomized Multiple Dose Pharmacokinetic Study of a Novel PDE10A Inhibitor TAK-063 in Subjects with Stable Schizophrenia and Japanese Subjects and Modeling of Exposure Relationships to Adverse Events

    A Randomized Multiple Dose Pharmacokinetic Study of a Novel PDE10A Inhibitor TAK-063 in Subjects with Stable Schizophrenia and Japanese Subjects and Modeling of Exposure Relationsh... by Goldsmith, Paul, Affinito, John, McCue, Maggie, Tsai, Max, Roepcke, Stefan, Xie, Jinhui, Gertsik, Lev, Macek, Thomas A.

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls

    Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls by Pearlman, Eric M., Wilbraham, Darren, Dennehy, Ellen B., Berg, Paul H., Tsai, Max, Doty, Erin G., Kay, Gary G.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine

    Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine by Tsai, Max, Nery, Emel Serap Monkul, Kerr, Lisa, Khanna, Rashna, Komori, Mika, Dennehy, Ellen B., Wilbraham, Darren, Winner, Paul

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients

    An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients by Gilleen, James, Farah, Yakub, Davison, Cate, Kerins, Sarah, Valdearenas, Lorena, Uz, Tolga, Lahu, Gez, Tsai, Max, Ogrinc, Frank, Reichenberg, Avi, Williams, Steve C., Mehta, Mitul A., Shergill, Sukhi S.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: